Exosomal microRNAs in cancer-related sarcopenia: Tumor-derived exosomal microRNAs in muscle atrophy. 2021

Chenyuan Li, and Qi Wu, and Zhiyu Li, and Zhong Wang, and Yi Tu, and Chuang Chen, and Si Sun, and Shengrong Sun
Department of Breast and Thyroid Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, PR China.

Cancer-associated sarcopenia is a complex metabolic syndrome marked by muscle mass wasting. Muscle wasting is a serious complication that is a primary contributor to cancer-related mortality. The underlying molecular mechanisms of cancer-associated sarcopenia have not been completely described to date. In general, evidence shows that the main pathophysiological alterations in sarcopenia are associated with the degradation of cellular components, an exceptional inflammatory secretome and mitochondrial dysfunction. Importantly, we highlight the prospect that several miRNAs carried by tumor-derived exosomes that have shown the ability to promote inflammatory secretion, activate catabolism, and even participate in the regulation of cellular degradation pathways can be delivered to and exert effects on muscle cells. In this review, we aim to describe the current knowledge about the functions of exosomal miRNAs in the induction of cancer-associated muscle wasting and propose potential treatment strategies.

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009133 Muscular Atrophy Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation. Atrophy, Muscle,Neurogenic Muscular Atrophy,Neurotrophic Muscular Atrophy,Atrophies, Muscle,Atrophies, Muscular,Atrophies, Neurogenic Muscular,Atrophies, Neurotrophic Muscular,Atrophy, Muscular,Atrophy, Neurogenic Muscular,Atrophy, Neurotrophic Muscular,Muscle Atrophies,Muscle Atrophy,Muscular Atrophies,Muscular Atrophies, Neurogenic,Muscular Atrophies, Neurotrophic,Muscular Atrophy, Neurogenic,Muscular Atrophy, Neurotrophic,Neurogenic Muscular Atrophies,Neurotrophic Muscular Atrophies
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D055354 Exosomes A type of extracellular vesicle, containing RNA and proteins, that is secreted into the extracellular space by EXOCYTOSIS when MULTIVESICULAR BODIES fuse with the PLASMA MEMBRANE.
D055948 Sarcopenia Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles. Sarcopenias
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Chenyuan Li, and Qi Wu, and Zhiyu Li, and Zhong Wang, and Yi Tu, and Chuang Chen, and Si Sun, and Shengrong Sun
November 2018, Molecular oncology,
Chenyuan Li, and Qi Wu, and Zhiyu Li, and Zhong Wang, and Yi Tu, and Chuang Chen, and Si Sun, and Shengrong Sun
June 2019, Journal of cellular physiology,
Chenyuan Li, and Qi Wu, and Zhiyu Li, and Zhong Wang, and Yi Tu, and Chuang Chen, and Si Sun, and Shengrong Sun
August 2019, Cancer science,
Chenyuan Li, and Qi Wu, and Zhiyu Li, and Zhong Wang, and Yi Tu, and Chuang Chen, and Si Sun, and Shengrong Sun
May 2020, Aging cell,
Chenyuan Li, and Qi Wu, and Zhiyu Li, and Zhong Wang, and Yi Tu, and Chuang Chen, and Si Sun, and Shengrong Sun
January 2024, Nutrients,
Chenyuan Li, and Qi Wu, and Zhiyu Li, and Zhong Wang, and Yi Tu, and Chuang Chen, and Si Sun, and Shengrong Sun
December 2017, Aging,
Chenyuan Li, and Qi Wu, and Zhiyu Li, and Zhong Wang, and Yi Tu, and Chuang Chen, and Si Sun, and Shengrong Sun
April 2015, Journal of experimental & clinical cancer research : CR,
Chenyuan Li, and Qi Wu, and Zhiyu Li, and Zhong Wang, and Yi Tu, and Chuang Chen, and Si Sun, and Shengrong Sun
December 2022, Adipocyte,
Chenyuan Li, and Qi Wu, and Zhiyu Li, and Zhong Wang, and Yi Tu, and Chuang Chen, and Si Sun, and Shengrong Sun
August 2019, International journal of molecular sciences,
Chenyuan Li, and Qi Wu, and Zhiyu Li, and Zhong Wang, and Yi Tu, and Chuang Chen, and Si Sun, and Shengrong Sun
November 2021, Biomedicines,
Copied contents to your clipboard!